Suchergebnisse - "Ravula, Jyothsna"

PubPharm (55)

1

Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Nirogi, R. | Ravula, J. | Benade, V. | +7

2

Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Nirogi, R. | Ravula, J. | Benade, V. | +7

3

AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATE

enthalten in: Europäisches Patentamt | 2023

von NIROGI RAMAKRISHNA | DOGIPARTI DHANUNJAY KUMAR | MUDIGONDA KOTESHWARA | +2

4

Method of treatment with histamine-3 receptor inverse agonist

enthalten in: Europäisches Patentamt | 2023

von NIROGI RAMAKRISHNA | SHINDE ANIL KARBHARI | BENADE VIJAY SIDRAM | +4

5

Method of treatment with histamine-3 receptor inverse agonist

enthalten in: Europäisches Patentamt | 2023

von NIROGI RAMAKRISHNA | SHINDE ANIL KARBHARI | BENADE VIJAY SIDRAM | +4

6

Masupirdine (SUVN‐502) for the Potential Treatment of Agitation in Patients with Dementia of the Alzheimer’s Type : Preliminary Efficacy and Phase‐3 Study Design

enthalten in: Alzheimer's & Dementia | 2023

von Nirogi, R. | Abraham, R. | Ravula, J. | +9

7

TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA PATIENTS

enthalten in: Europäisches Patentamt | 2022

von NIROGI RAMAKRISHNA | SHINDE ANIL KARBHARI | JAYARAJAN PRADEEP | +9

8

Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502) : A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study

enthalten in: Neurology and therapy | 2022

von Nirogi, R. | Goyal, V. | Benade, V. | +8

9

AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATE

enthalten in: Europäisches Patentamt | 2022

von NIROGI RAMAKRISHNA | DOGIPARTI DHANUNJAY KUMAR | MUDIGONDA KOTESHWARA | +2

10

TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA PATIENTS

enthalten in: Europäisches Patentamt | 2022

von NIROGI RAMAKRISHNA | SHINDE ANIL KARBHARI | JAYARAJAN PRADEEP | +9

1
2
3
4
5
6
Nächster »
[6]